Literature DB >> 34292884

Active surveillance characterizes human intratumoral T cell exhaustion.

Ran You1,2, Jordan Artichoker2,3, Adam Fries2,3, Austin W Edwards2,3, Alexis J Combes2, Gabriella C Reeder2, Bushra Samad2, Matthew F Krummel1,2,3.   

Abstract

Intratumoral T cells that might otherwise control tumors are often identified in an "exhausted" state, defined by specific epigenetic modifications and upregulation of genes such as CD38, cytotoxic T-lymphocyte-associated protein 4 (CTLA4), and programmed cell death 1 (PD1). Although the term might imply inactivity, there has been little study of this state at the phenotypic level in tumors to understand the extent of their incapacitation. Starting with the observation that T cells move more quickly through mouse tumors the longer they reside there and progress toward exhaustion, we developed a nonstimulatory, live-biopsy method for the real-time study of T cell behavior within individual patient tumors. Using 2-photon microscopy, we studied native CD8+ T cell interaction with antigen-presenting cells (APCs) and cancer cells in different microniches of human tumors and found that T cell speed was variable by region and by patient and was inversely correlated with local tumor density. Across a range of tumor types, we found a strong relationship between CD8+ T cell motility and the exhausted T cell state that corresponded with our observations made in mouse models in which exhausted T cells moved faster. Our study demonstrates T cell dynamic states in individual human tumors and supports the existence of an active program in "exhausted" T cells that extends beyond incapacitating them.

Entities:  

Keywords:  Cancer; Immunology; Oncology; T cells

Mesh:

Year:  2021        PMID: 34292884      PMCID: PMC8439597          DOI: 10.1172/JCI144353

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity.

Authors:  Stéphanie Hugues; Luc Fetler; Laura Bonifaz; Julie Helft; François Amblard; Sebastian Amigorena
Journal:  Nat Immunol       Date:  2004-10-31       Impact factor: 25.606

2.  In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor.

Authors:  Alexandre Boissonnas; Luc Fetler; Ingrid S Zeelenberg; Stéphanie Hugues; Sebastian Amigorena
Journal:  J Exp Med       Date:  2007-01-29       Impact factor: 14.307

Review 3.  Two-photon imaging of the immune system: a custom technology platform for high-speed, multicolor tissue imaging of immune responses.

Authors:  Andrew Bullen; Rachel S Friedman; Matthew F Krummel
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

4.  Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.

Authors:  John J Engelhardt; Bijan Boldajipour; Peter Beemiller; Priya Pandurangi; Caitlin Sorensen; Zena Werb; Mikala Egeblad; Matthew F Krummel
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 5.  Defining 'T cell exhaustion'.

Authors:  Christian U Blank; W Nicholas Haining; Werner Held; Patrick G Hogan; Axel Kallies; Enrico Lugli; Rachel C Lynn; Mary Philip; Anjana Rao; Nicholas P Restifo; Andrea Schietinger; Ton N Schumacher; Pamela L Schwartzberg; Arlene H Sharpe; Daniel E Speiser; E John Wherry; Benjamin A Youngblood; Dietmar Zehn
Journal:  Nat Rev Immunol       Date:  2019-09-30       Impact factor: 53.106

6.  Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.

Authors:  Hélène Salmon; Katarzyna Franciszkiewicz; Diane Damotte; Marie-Caroline Dieu-Nosjean; Pierre Validire; Alain Trautmann; Fathia Mami-Chouaib; Emmanuel Donnadieu
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

7.  T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Authors:  Alexander C Huang; Michael A Postow; Robert J Orlowski; Rosemarie Mick; Bertram Bengsch; Sasikanth Manne; Wei Xu; Shannon Harmon; Josephine R Giles; Brandon Wenz; Matthew Adamow; Deborah Kuk; Katherine S Panageas; Cristina Carrera; Phillip Wong; Felix Quagliarello; Bradley Wubbenhorst; Kurt D'Andrea; Kristen E Pauken; Ramin S Herati; Ryan P Staupe; Jason M Schenkel; Suzanne McGettigan; Shawn Kothari; Sangeeth M George; Robert H Vonderheide; Ravi K Amaravadi; Giorgos C Karakousis; Lynn M Schuchter; Xiaowei Xu; Katherine L Nathanson; Jedd D Wolchok; Tara C Gangadhar; E John Wherry
Journal:  Nature       Date:  2017-04-10       Impact factor: 49.962

8.  Water-soluble quantum dots for multiphoton fluorescence imaging in vivo.

Authors:  Daniel R Larson; Warren R Zipfel; Rebecca M Williams; Stephen W Clark; Marcel P Bruchez; Frank W Wise; Watt W Webb
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

9.  Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Authors:  Hanjie Li; Anne M van der Leun; Ido Yofe; Yaniv Lubling; Dikla Gelbard-Solodkin; Alexander C J van Akkooi; Marlous van den Braber; Elisa A Rozeman; John B A G Haanen; Christian U Blank; Hugo M Horlings; Eyal David; Yael Baran; Akhiad Bercovich; Aviezer Lifshitz; Ton N Schumacher; Amos Tanay; Ido Amit
Journal:  Cell       Date:  2018-12-27       Impact factor: 41.582

10.  Chromatin states define tumour-specific T cell dysfunction and reprogramming.

Authors:  Mary Philip; Lauren Fairchild; Liping Sun; Ellen L Horste; Steven Camara; Mojdeh Shakiba; Andrew C Scott; Agnes Viale; Peter Lauer; Taha Merghoub; Matthew D Hellmann; Jedd D Wolchok; Christina S Leslie; Andrea Schietinger
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

View more
  7 in total

1.  Tireless surveillance by exhausted T cells.

Authors:  Michael L Dustin
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

2.  Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.

Authors:  Simon Wabitsch; Justin D McCallen; Olena Kamenyeva; Benjamin Ruf; John C McVey; Juraj Kabat; Juliane S Walz; Yaron Rotman; Kylynda C Bauer; Amanda J Craig; Marie Pouzolles; Ira Phadke; Vanessa Catania; Benjamin L Green; Claude Fu; Laurence P Diggs; Bernd Heinrich; Xin Wei Wang; Chi Ma; Tim F Greten
Journal:  J Hepatol       Date:  2022-04-01       Impact factor: 30.083

Review 3.  Autoimmunity in motion: Mechanisms of immune regulation and destruction revealed by in vivo imaging.

Authors:  Jordan Jacobelli; Alan E Buser; Dustin L Heiden; Rachel S Friedman
Journal:  Immunol Rev       Date:  2021-11-25       Impact factor: 10.983

4.  Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy.

Authors:  Ran You; Jordan Artichoker; Arja Ray; Hugo Gonzalez Velozo; Dan A Rock; Kip P Conner; Matthew F Krummel
Journal:  Cancer Immunol Res       Date:  2022-06-03       Impact factor: 12.020

Review 5.  Immune Checkpoint Proteins, Metabolism and Adhesion Molecules: Overlooked Determinants of CAR T-Cell Migration?

Authors:  Luca Simula; Emma Ollivier; Philippe Icard; Emmanuel Donnadieu
Journal:  Cells       Date:  2022-06-06       Impact factor: 7.666

Review 6.  Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.

Authors:  Kirit Singh; Kelly M Hotchkiss; Kisha K Patel; Daniel S Wilkinson; Aditya A Mohan; Sarah L Cook; John H Sampson
Journal:  Cancers (Basel)       Date:  2021-10-26       Impact factor: 6.639

7.  Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.

Authors:  Parin Shah; Marie-Andrée Forget; Meredith L Frank; Peixin Jiang; Donastas Sakellariou-Thompson; Lorenzo Federico; Roohussaba Khairullah; Chantal Alexia Neutzler; Ignacio Wistuba; Chi-Wan B Chow; Yan Long; Junya Fujimoto; Shiaw-Yih Lin; Anirban Maitra; Marcelo V Negrao; Kyle Gregory Mitchell; Annikka Weissferdt; Ara A Vaporciyan; Tina Cascone; Jack A Roth; Jianjun Zhang; Boris Sepesi; Don L Gibbons; John V Heymach; Cara L Haymaker; Daniel J McGrail; Alexandre Reuben; Chantale Bernatchez
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.